Naxitamab and GM-CSF in People With Neuroblastoma
NCT04501757
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
High-Risk Neuroblastoma
Interventions
BIOLOGICAL:
Naxitamab/GM-CSF
Sponsor
Memorial Sloan Kettering Cancer Center